Middle East and Africa Antibodies Industry by product type - (Monoclonal Antibodies, Polyclonal Antibodies, Anti-body drug complexes), by Indication – (Cancer, Auto immune diseases, Infectious diseases, Cardiovascular diseases, CNS disorders, others), by End user (Hospitals/clinics, Research institute, Diagnostics laboratories), by Application (Medical, Experimental) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
According to the report Middle East and Africa Antibodies Industry, published by Market Data Forecast, The Industry was worth $ 5.713 Billion in 2016 and estimated to reach $ 7.417 million by the end of 2021 with a growing potential of 5.36 %.
Antibodies (Ab’s) are proteins produced by Plasma cells (differentiated B-Cells) that helps the immune system to detect and neutralize pathogens such as Viruses and bacteria. Antibodies can be triggered and directed at microorganisms, foreign proteins, and toxins.
These antibodies are used as diagnostics as well as Therapeutic purposes for several indications of diseases, including but not limited to, rheumatoid arthritis, Crohn’s disease, macular degeneration, asthma, and hypercholesterolemia.
Browse Market data tables and in-depth TOC of the Middle East and Africa Antibodies Industry to 2021 at www.marketdataforecast.com/market-…dies-market-1182/
Some of the major factors that are influencing the Middle East and Africa Antibodies Industry are rising rate of adoption to therapeutic antibodies in cost sensitive Industry, innovative products, growing chronic illnesses due to population shift and increasing longevity, quick approval for breakthrough therapies by regulatory authorities, and adoption of diagnostic antibodies. Side effects associated with antibodies treatment and increasing cost of treatment are the factors that are hampering the growth of the Industry.
Based on product type, the Industry is segmented into Monoclonal Antibodies, Polyclonal Antibodies, and Anti-body drug complexes. The monoclonal antibodies are further segmented into Murine, Chimeric, Humanized, and Human.
The polyclonal antibodies are further categorized into Type I, Type II, Type III, Type IV, Type V, Type VI, Type VII, Type VIII. The Antibody-Drug Complexes are further segmented into Immunogen Technology, Seattle Genetics Technology, and Immunomedics Technology.
Based on Indication, the Industry is segmented into Cancer, Auto immune diseases, Infectious diseases, cardiovascular diseases, and CNS disorders, others (Inflammatory, Microbial Diseases, & Other). Based on end users, the Industry is segmented into Hospitals/Clinics, Research institute, Diagnostics laboratories.
Based on Application, the Industry is segmented into Medical, Experimental. The Experimental segment is further categorized into Western blot, ELISA, Radioimmune Assays, immunofluorescence, others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry).
Based on Geography, the Middle East and Africa Antibodies Industry is analysed under various regions namely Middle East, Africa.
The key players that are dominating the Middle East and Africa Antibodies Industry are Abbott Diagnostics, Novartis AG, Pfizer Inc., ThermoFisher Scientific Inc., Eli Lilly and company, A.G. Scientific, Inc., Bristol-Myers Squibb, F.
Hoffmann-La Roche Ltd., AbbVie Inc.
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Middle East and Africa Antibodies Industry Segmentation
- By Product Type
- By Indication
- End User
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!